Gemina Laboratories Financials
| GLABF Stock | USD 0.55 0.01 1.79% |
With this module, you can analyze Gemina financials for your investing period. You should be able to track the changes in Gemina Laboratories individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Gemina |
Understanding current and past Gemina Laboratories Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Gemina Laboratories' financial statements are interrelated, with each one affecting the others. For example, an increase in Gemina Laboratories' assets may result in an increase in income on the income statement.
The data published in Gemina Laboratories' official financial statements typically reflect Gemina Laboratories' business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Gemina Laboratories' quantitative information. For example, before you start analyzing numbers published by Gemina accountants, it's essential to understand Gemina Laboratories' liquidity, profitability, and earnings quality within the context of the Healthcare space in which it operates.
Gemina Laboratories Stock Summary
Gemina Laboratories competes with Novo Nordisk, Genmab AS, Inhibikase Therapeutics, Purple Biotech, and Synaptogenix. Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada. It is developing POC Antigen COVID test, a point-of-care lateral flow assay test strip to test whether or not a person is currently infected with COVID-19. Gemina Laboratories operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 5 people.| Instrument | USA OTC Stock View All |
| Exchange | OTCQB Exchange |
| Business Address | 3800 Westbrook Mall, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.geminalabs.com |
| Phone | 604 760 1997 |
| Currency | USD - US Dollar |
Gemina Laboratories Key Financial Ratios
There are many critical financial ratios that Gemina Laboratories' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Gemina Laboratories reports annually and quarterly.Gemina Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Gemina Laboratories's current stock value. Our valuation model uses many indicators to compare Gemina Laboratories value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Gemina Laboratories competition to find correlations between indicators driving Gemina Laboratories's intrinsic value. More Info.Gemina Laboratories is rated # 2 in return on equity category among its peers. It is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Gemina Laboratories' earnings, one of the primary drivers of an investment's value.Gemina Laboratories Systematic Risk
Gemina Laboratories' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Gemina Laboratories volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on Gemina Laboratories correlated with the market. If Beta is less than 0 Gemina Laboratories generally moves in the opposite direction as compared to the market. If Gemina Laboratories Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Gemina Laboratories is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Gemina Laboratories is generally in the same direction as the market. If Beta > 1 Gemina Laboratories moves generally in the same direction as, but more than the movement of the benchmark.
Gemina Laboratories November 30, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Gemina Laboratories help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Gemina Laboratories. We use our internally-developed statistical techniques to arrive at the intrinsic value of Gemina Laboratories based on widely used predictive technical indicators. In general, we focus on analyzing Gemina OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Gemina Laboratories's daily price indicators and compare them against related drivers.
| Downside Deviation | 11.33 | |||
| Information Ratio | 0.1379 | |||
| Maximum Drawdown | 39.68 | |||
| Value At Risk | (5.00) | |||
| Potential Upside | 17.65 |
Complementary Tools for Gemina OTC Stock analysis
When running Gemina Laboratories' price analysis, check to measure Gemina Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gemina Laboratories is operating at the current time. Most of Gemina Laboratories' value examination focuses on studying past and present price action to predict the probability of Gemina Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gemina Laboratories' price. Additionally, you may evaluate how the addition of Gemina Laboratories to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |